nitrites has been researched along with Melanoma in 13 studies
Nitrites: Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of congeners of nitrogen monoxide (NO) on iron (Fe) uptake from 59Fe-125I-transferrin (Tf) and release of 59Fe from prelabelled cells have been investigated in SK-MEL-28 human melanoma cells, human K562 cells and mouse MDW-4 cells." | 3.69 | Nitrogen monoxide decreases iron uptake from transferrin but does not mobilise iron from prelabelled neoplastic cells. ( Neumannova, V; Ponka, P; Richardson, DR, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Zimmermann, T | 1 |
| Gebhardt, LA | 1 |
| Kreiss, L | 1 |
| Schneider, C | 1 |
| Arndt, S | 1 |
| Karrer, S | 1 |
| Friedrich, O | 1 |
| Fischer, MJM | 1 |
| Bosserhoff, AK | 1 |
| Azzariti, A | 1 |
| Iacobazzi, RM | 1 |
| Di Fonte, R | 1 |
| Porcelli, L | 1 |
| Gristina, R | 1 |
| Favia, P | 1 |
| Fracassi, F | 1 |
| Trizio, I | 1 |
| Silvestris, N | 1 |
| Guida, G | 1 |
| Tommasi, S | 1 |
| Sardella, E | 1 |
| Fekkes, D | 1 |
| Van Gool, AR | 1 |
| Bannink, M | 1 |
| Sleijfer, S | 1 |
| Kruit, WH | 1 |
| van der Holt, B | 1 |
| Eggermont, AM | 1 |
| Hengeveld, MW | 1 |
| Stoter, G | 1 |
| Rhenals, MV | 1 |
| Strasberg-Rieber, M | 1 |
| Rieber, M | 1 |
| Ishii, Y | 1 |
| Ogura, T | 1 |
| Tatemichi, M | 1 |
| Fujisawa, H | 1 |
| Otsuka, F | 1 |
| Esumi, H | 1 |
| Han, SB | 1 |
| Lee, CW | 1 |
| Kang, JS | 1 |
| Yoon, YD | 1 |
| Lee, KH | 1 |
| Lee, K | 1 |
| Park, SK | 1 |
| Kim, HM | 1 |
| Ferrer, P | 1 |
| Asensi, M | 1 |
| Priego, S | 1 |
| Benlloch, M | 1 |
| Mena, S | 1 |
| Ortega, A | 1 |
| Obrador, E | 1 |
| Esteve, JM | 1 |
| Estrela, JM | 1 |
| Ma, SF | 1 |
| Nishikawa, M | 1 |
| Hyoudou, K | 1 |
| Takahashi, R | 1 |
| Ikemura, M | 1 |
| Kobayashi, Y | 1 |
| Yamashita, F | 1 |
| Hashida, M | 1 |
| Richardson, DR | 1 |
| Neumannova, V | 1 |
| Ponka, P | 1 |
| Ogilvie, AC | 1 |
| Hack, CE | 1 |
| Wagstaff, J | 1 |
| van Mierlo, GJ | 1 |
| Erenberg, AJ | 1 |
| Thomsen, LL | 1 |
| Hoekman, K | 1 |
| Rankin, EM | 1 |
| Citterio, G | 1 |
| Pellegatta, F | 1 |
| Lucca, GD | 1 |
| Fragasso, G | 1 |
| Scaglietti, U | 1 |
| Pini, D | 1 |
| Fortis, C | 1 |
| Tresoldi, M | 1 |
| Rugarli, C | 1 |
| Grimm, EA | 1 |
| Smid, CM | 1 |
| Lee, JJ | 1 |
| Tseng, CH | 1 |
| Eton, O | 1 |
| Buzaid, AC | 1 |
| Wang, B | 1 |
| Xiong, Q | 1 |
| Shi, Q | 1 |
| Tan, D | 1 |
| Le, X | 1 |
| Xie, K | 1 |
3 trials available for nitrites and Melanoma
| Article | Year |
|---|---|
IL-1 beta does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer.
Topics: Adult; Antineoplastic Agents; Cell Degranulation; Complement Activation; Female; Humans; Interleukin | 1996 |
Plasma nitrate plus nitrite changes during continuous intravenous infusion interleukin 2.
Topics: Adult; Aged; Carcinoma, Renal Cell; Cardiovascular Diseases; Drug Administration Schedule; Female; H | 1996 |
Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytokines; Dacarbazine; Enzyme-Lin | 2000 |
10 other studies available for nitrites and Melanoma
| Article | Year |
|---|---|
Acidified Nitrite Contributes to the Antitumor Effect of Cold Atmospheric Plasma on Melanoma Cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; DNA Damage; Humans; MAP Kinase Si | 2021 |
Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells.
Topics: Calreticulin; Cell Death; Cell Line, Tumor; Cell Survival; Culture Media; Electricity; Humans; Hydro | 2019 |
Nitric oxide production and monoamine oxidase activity in cancer patients during interferon-alpha therapy.
Topics: Adult; Aged; Arginine; Blood Platelets; Carcinoma, Renal Cell; Citrulline; Female; Humans; Interfero | 2009 |
Nitric oxide donors or nitrite counteract copper-[dithiocarbamate](2)-mediated tumor cell death and inducible nitric oxide synthase down-regulation: possible role of a nitrosyl-copper [dithiocarbamate](2) complex.
Topics: Cell Death; Cell Line, Tumor; Cell Survival; Cobalt; Cyclic N-Oxides; Down-Regulation; Free Radical | 2010 |
Induction of matrix metalloproteinase gene transcription by nitric oxide and mechanisms of MMP-1 gene induction in human melanoma cell lines.
Topics: Blotting, Northern; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases; DNA Primers; El | 2003 |
Acidic polysaccharide from Phellinus linteus inhibits melanoma cell metastasis by blocking cell adhesion and invasion.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents, Phytogenic; Basidiomycota; Cell Adhesion; Ce | 2006 |
Nitric oxide mediates natural polyphenol-induced Bcl-2 down-regulation and activation of cell death in metastatic B16 melanoma.
Topics: Animals; Cell Adhesion; Cell Death; Cell Line, Tumor; Down-Regulation; Endothelium, Vascular; Flavon | 2007 |
Combining cisplatin with cationized catalase decreases nephrotoxicity while improving antitumor activity.
Topics: Animals; Animals, Outbred Strains; Antineoplastic Agents; Antioxidants; Blood Urea Nitrogen; Catalas | 2007 |
Nitrogen monoxide decreases iron uptake from transferrin but does not mobilise iron from prelabelled neoplastic cells.
Topics: Animals; Cell Line; Cyclic GMP; Humans; Iodine Radioisotopes; Iron; Iron Radioisotopes; Melanoma; Mi | 1995 |
Genetic disruption of host nitric oxide synthase II gene impairs melanoma-induced angiogenesis and suppresses pleural effusion.
Topics: Animals; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Genes, p53; Immunohistochemi | 2001 |